Expertise

Five specialised practices. One objective.

Focused business development across five connected pillars of the pharmaceutical value chain. Every mandate is tailored to the asset and to your strategic goals.

01
01 · Pharmaceutical Sourcing

Qualified products. Audited supply partners.

Reliable, compliant supply protects margins and market continuity. Generix identifies and qualifies manufacturers, product owners and CMO/CDMO partners aligned with your portfolio strategy.

We cover targeted product and API/finished-dosage sourcing, supplier capability screening (EU-GMP / PIC/S), feasibility benchmarking and negotiations on MOQs, lead times and long-term supply terms.

Discuss your product requirements
02
02 · Licensing & Dossier Supply

Monetising pharmaceutical assets across territories.

Well-structured dossiers and Marketing Authorisations are high-margin growth levers when matched with the right regional operators. We connect dossier owners and MAHs with qualified licensees seeking proven Rx, OTC and value-added formulations.

We originate and structure in-licensing, out-licensing, MA transfers and dossier acquisitions, often paired with long-term supply agreements, and manage partner screening, non-confidential teasers, CDAs and preliminary term sheets.

All regulatory filings, variations, pharmacovigilance obligations and contractual transfers are carried out strictly between the authorised entities, in line with applicable pharmaceutical legislation.

Explore licensing opportunities
03
03 · Strategic Business Development

Turning pipeline strategy into executed partnerships.

Internal BD teams often lack bandwidth when entering unfamiliar territories or evaluating niche therapeutic segments. Generix acts as an agile, senior-level extension of your commercial team.

We run partner mapping, opportunity qualification, executive outreach and negotiation support, so your leadership only meets pre-vetted, decision-ready counterparties.

Develop your next partnership
04
04 · Market Access & Distribution

Bridging European quality with regional demand.

International expansion needs partners with regulatory infrastructure, tender access and distribution reach. We help manufacturers and product owners build structured market-entry pathways across Europe, the Middle East (MENA) and selected international markets.

We identify and vet local distributors, evaluate market-entry models and structure exclusive or semi-exclusive distribution frameworks.

All product registration, importation, batch release and wholesale distribution are carried out exclusively by locally licensed, authorised counterparties.

Explore new markets
05
05 · Mergers & Acquisitions

Discreet introductions and asset divestments.

Acquisitions, brand divestments and cross-border joint ventures help pharmaceutical companies scale faster and sharpen portfolio focus. Generix facilitates confidential introductions between business owners, strategic acquirers and institutional investors.

We handle discreet counterparty identification, confidential mandate positioning and initial alignment. As transactions move to formal execution, we work alongside qualified legal, tax, financial and regulatory advisers.

Discuss a confidential opportunity

Accelerate your next transaction.

Whether you are expanding your therapeutic portfolio, monetising existing dossiers or entering new international territories, Generix brings the reach and discipline to execute.